- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Mass prostate cancer screenings don’t reduce death
January 9, 2012
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: Implications for androgen-deprivation therapy - Abstract
January 6, 2012
Patients' satisfaction with different modalities of prostate cancer therapy--a retrospective survey among 634 patients - Abstract
January 6, 2012
Effect of zoledronic acid on bone mineral density in men with prostate cancer receiving gonadotropin-releasing hormone analog - Abstract
January 6, 2012
Younger age is an independent predictor for poor survival in patients with signet ring prostate carcinoma - Abstract
January 6, 2012
An update on the changing indications for androgen deprivation therapy for prostate cancer - Abstract
January 6, 2012
Temporal compartmental dosing effects for robotic prostate stereotactic body radiotherapy - Abstract
January 5, 2012
Mathematical modeling of prostate cancer progression in response to androgen ablation therapy - Abstract
January 5, 2012
Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population - Abstract
January 5, 2012
Prediction of prostate cancer risk: The role of prostate volume and digital rectal examination in the ERSPC risk calculators - Abstract
January 5, 2012
Acoustic radiation force impulse imaging of human prostates: Initial in vivo demonstration - Abstract
January 5, 2012
Pathological outcomes of men eligible for active surveillance after undergoing radical prostatectomy: Are results predictable? - Abstract
January 5, 2012
Matched cohort analysis of outcomes of definitive radiotherapy for prostate cancer in human immunodeficiency virus-positive patients - Abstract
January 5, 2012